147 results
8-K
8n7jgnlowemh1wvtvr
31 Aug 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:19pm
8-K
EX-10.4
uowpt0ulxmkploayw
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
8-K
EX-10.2
3xp8qub7
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
8-K
EX-10.3
hmggu
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
425
n95cqa4yh49pge7vv5l7
30 May 23
Business combination disclosure
4:21pm
8-K
m1plaxz 2o6
30 May 23
Submission of Matters to a Vote of Security Holders
4:18pm
425
hoty7p0
22 May 23
Business combination disclosure
7:01am
8-K
14kw58uig3
22 May 23
Other Events
6:59am